IP Library Granted Patent US 9,650,606
Granted Patent B2
US 9,650,606 · App. 14/299,802 · Granted May 16, 2017

Method of co-culturing mammalian muscle cells and motoneurons

Inventors: James Hickman (Orlando, FL); Mainak Das (Orlando, FL)
Assignee: University of Central Florida Research Foundation, Inc.
C12N5/0619C12N5/0658C12N2500/90C12N2502/088C12N2502/1335
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,650,606
App. No.
14/299,802
Granted
May 16, 2017
Kind
B2
Abstract

The invention provides a method of co-culturing mammalian muscle cells and mammalian motoneurons. The method comprises preparing one or more carriers coated with a covalently bonded monolayer of trimethoxysilylpropyl diethylenetriamine (DETA); suspending isolated fetal mammalian skeletal muscle cells in serum-free medium according to medium composition 1; suspending isolated fetal mammalian spinal motoneurons in serum-free medium according to medium composition 1; plating the suspended muscle cells onto the one or more carriers at a predetermined density and allowing the muscle cells to attach; plating the suspended motoneurons at a predetermined density onto the one or more carriers and allowing the motoneurons to attach; covering the one or more carriers with a mixture of medium composition 1 and medium composition 2; and incubating the carriers covered in the media mixture.

Claims (7)

1. A co-culture for forming at least one synthetic mammalian neuromuscular junction, comprising: fetal mammalian skeletal muscle cells adhered to an artificial surface and overlayered with fetal mammalian spinal motoneurons in a serum-free medium, wherein the serum-free medium comprises a mixture of the components of Table 3 at the concentrations listed in Table 3, the components of Table 4 at the concentrations listed in Table 4, the components of Table 5 at the concentrations listed in Table 5, creatine, estrogen, and cholesterol.

2. The co-culture of claim 1 , wherein one or more of the fetal mammalian spinal motoneurons is functionally linked to one or more of the fetal mammalian skeletal muscle cells.

3. The co-culture of claim 1 , wherein the artificial surface comprises a silicon based monolayer substrate deposited thereon.

4. The co-culture of claim 3 , wherein the silicon based monolayer substrate is deposited in a predetermined pattern.

5. The co-culture of claim 3 , wherein the silicon based monolayer substrate comprises trimethoxysilylpropyl diethylenetriamine (DETA).

6. The co-culture of claim 1 , wherein the fetal mammalian skeletal muscle cells have a density of about from 700 to about 1000 cells/mm 2 .

7. The co-culture of claim 1 , wherein the fetal mammalian spinal motoneurons have a density of about 100 cells/mm 2 .

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 16, 2017
From: UNIVERSITY OF CENTRAL FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 043569/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2014
From: HICKMAN, JAMES; DAS, MAINAK
To: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 033163/0081 →
Continuity (3)
Continuation 12765996 · Apr 23, 2010
Provisional Application 61171958 · Apr 23, 2009
Related Publication 20140302599A1 · Oct 9, 2014